High-dose therapy and stem cell transplant (SCT) in follicular (FL) and mantle-cell lymphomas (MCL).

被引：0
|
作者：
López, R [1 ]
Martino, R [1 ]
Brunet, S [1 ]
Muñoz, L [1 ]
Sureda, A [1 ]
Domingo, A [1 ]
Sierra, J [1 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Clin Hematol Div, Barcelona, Spain
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
607
引用
收藏
页码：S175 / S175
页数：1
相关论文
共 50 条
  • [31] Update of the HCVAD regimen followed by stem cell transplantation (SCT) in mantle cell lymphoma (MCL).
    Khouri, I
    Romaguera, J
    Kantarjian, H
    Korbling, M
    Younes, A
    Giralt, S
    Hagemeister, F
    Gajewski, J
    Sarris, A
    Claxton, D
    McLaughlin, P
    Donato, M
    Rodriguez, M
    Ueno, N
    Champlin, R
    Cabanillas, F
    BLOOD, 1999, 94 (10) : 610A - 610A
  • [32] Mantle cell lymphoma (MCL):: Induction therapy with HyperCVAD/High-dose methotrexate and cytarabine (M-C) (±rituximab) improves results of autologous stem cell transplant in first remission.
    Vose, J.
    Loberiza, F.
    Bierman, P.
    Bociek, G.
    Armitage, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 424S - 424S
  • [33] High-dose therapy (HDT) with stem cell transplantation (BMT) for mantle cell lymphoma (MCL):: Results and prognostic factors.: A single center experience.
    Milpied, N
    Gaillard, F
    Moreau, P
    Mahé, B
    Souchet, J
    Rapp, MJ
    Bulabois, CE
    Morineau, N
    Harousseau, JL
    BONE MARROW TRANSPLANTATION, 1998, 21 : S173 - S173
  • [34] High-dose therapy (HDT) with stem cell transplantation (BMT) for mantle cell lymphoma (MCL): Results and prognostic factors. A single center experience.
    Milpied, N
    Gaillard, F
    Moreau, P
    Mahe, B
    Souchet, J
    Rapp, MJ
    Bulabois, CE
    Morineau, N
    Harousseau, JL
    BLOOD, 1997, 90 (10) : 1693 - 1693
  • [35] Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: An active regimen for aggressive mantle-cell lymphoma
    Khouri, IF
    Romaguera, J
    Kantarjian, H
    Palmer, JL
    Pugh, WC
    Korbling, M
    Hagemeister, F
    Samuels, B
    Rodriguez, A
    Giralt, S
    Younes, A
    Przepiorka, D
    Claxton, D
    Cabanillas, F
    Champlin, R
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) : 3803 - 3809
  • [36] High-dose therapy for mantle cell lymphoma - the Nottingham experience
    Jones, SG
    Gilyead, M
    Russell, NH
    Haynes, AP
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 : 37 - 37
  • [37] Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma
    Thieblemont, C
    Antal, D
    Lacotte-Thierry, L
    Delwail, V
    Espinouse, D
    Michallet, AS
    Traulle, C
    Bouafia-Sauvy, F
    Giraud, C
    Salles, G
    Guilhot, F
    Coiffier, B
    CANCER, 2005, 104 (07) : 1434 - 1441
  • [38] Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma
    Nastoupil, Loretta J.
    Shenoy, Pareen J.
    Ambinder, Alex
    Koff, Jean L.
    Nooka, Ajay K.
    Waller, Edmund K.
    Langston, Amelia
    Seward, Miray
    Kaufman, Jonathan L.
    Bernal-Mizrachi, Leon
    King, Nassoma
    Lechowicz, Mary Jo
    Lonial, Sagar
    Sinha, Rajni
    Flowers, Christopher R.
    LEUKEMIA & LYMPHOMA, 2015, 56 (02) : 383 - 389
  • [39] Consolidation with High Dose Therapy and Autologous Stem Cell Transplant Improves Survival for Patients with Mantle Cell Lymphoma
    Nastoupil, Loretta
    Shenoy, Pareen J.
    Ambinder, Alex
    Seward, Miray
    Nooka, Ajay K.
    Waller, Edmund K.
    Langston, Amelia
    Kaufman, Jonathan L.
    King, Nassoma
    Lechowicz, Mary Jo
    Lonial, Sagar
    Sinha, Rajni
    Flowers, Christopher R.
    BLOOD, 2012, 120 (21)
  • [40] Low dose recombinent interleukin 2 (rIL-2) following high-dose chemotherapy (HDC) and autologous peripheral blood stem cell transplantation (PBSCT) in patients with chronic lymphocytic leukemia (CLL), mantle cell (MCL), and follicular lymphoma (FL).
    Waselenko, JK
    Burrows, A
    Lucas, M
    Ekstrand, JR
    Myhand, R
    Lee, N
    Edenfield, WJ
    Byrd, JC
    BLOOD, 2000, 96 (11) : 350B - 350B
12345